- Home
- MGX vs YGMZ Comparison
MGX vs YGMZ Comparison
Compare MGX & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGX
- YGMZ
- Stock Information
- Founded
- MGX 2018
- YGMZ 2002
- Country
- MGX United States
- YGMZ China
- Employees
- MGX N/A
- YGMZ 26
- Industry
- MGX
- YGMZ Transportation Services
- Sector
- MGX
- YGMZ Consumer Discretionary
- Exchange
- MGX NYSE
- YGMZ Nasdaq
- Market Cap
- MGX 62.1M
- YGMZ 62.1M
- IPO Year
- MGX 2024
- YGMZ 2020
- Fundamental
- Price
- MGX $2.08
- YGMZ $0.71
- Analyst Decision
- MGX Strong Buy
- YGMZ
- Analyst Count
- MGX 4
- YGMZ 0
- Target Price
- MGX $13.00
- YGMZ N/A
- AVG Volume (30 Days)
- MGX 916.2K
- YGMZ 180.8K
- Earning Date
- MGX 08-13-2025
- YGMZ 01-01-0001
- Dividend Yield
- MGX N/A
- YGMZ N/A
- EPS Growth
- MGX N/A
- YGMZ N/A
- EPS
- MGX N/A
- YGMZ N/A
- Revenue
- MGX $45,263,000.00
- YGMZ $40,429,750.00
- Revenue This Year
- MGX N/A
- YGMZ N/A
- Revenue Next Year
- MGX $11.75
- YGMZ N/A
- P/E Ratio
- MGX N/A
- YGMZ N/A
- Revenue Growth
- MGX N/A
- YGMZ N/A
- 52 Week Low
- MGX $1.23
- YGMZ $0.64
- 52 Week High
- MGX $5.49
- YGMZ $1.77
- Technical
- Relative Strength Index (RSI)
- MGX 62.36
- YGMZ 24.86
- Support Level
- MGX $2.04
- YGMZ $0.74
- Resistance Level
- MGX $2.47
- YGMZ $1.12
- Average True Range (ATR)
- MGX 0.18
- YGMZ 0.07
- MACD
- MGX 0.07
- YGMZ -0.03
- Stochastic Oscillator
- MGX 61.76
- YGMZ 0.00
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
About YGMZ MingZhu Logistics Holdings Limited
MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. The segments of the company are the trucking business, car owner services business, and liquor distribution business.